Integrated Virtual Screening and Molecular Electrostatic Surface Potential Descriptors for Predicting BACE1 Inhibitor Interactions in Alzheimer's Disease.

Overview

1. Universidad de la Habana, Facultad de Química, Havana 10400, Cuba
2. Universidad Autónoma de Madrid, Química Física Aplicada, Madrid, 28049 Madrid, Spain
3. Center for Pharmaceuticals Research and Development (CIDEM), La Habana 10400, Cuba

Abstract

Developing brain-penetrant BACE1 inhibitors remains a major challenge in Alzheimer’s disease. Unlike conventional studies focusing solely on binding affinity, this work presents an integrated computational pipeline that prioritizes both potency and pharmacokinetic developability from the outset. A robust quantitative structure–activity relationship (QSAR) model was built for 41 N-(pyridin-3-yl)­picolinamide derivatives using Molecular Electrostatic Surface Potential (MESP) descriptors. Principal component analysis identified three key electrostatic features – mean MESP, variance of negative MESP, and number of local MESP maxima/minima as drivers of BACE1 inhibitory activity. A key novelty is the early integration of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) filtering, using ADMETlab 3.0, to ensure blood-brain barrier (BBB) permeability and low P-glycoprotein efflux properties whose absence contributed to the failure of several clinical BACE1 inhibitors. Only compound N-[3-[(1S,5S,6S)-3-amino-1-(difluoromethyl)-5-(fluoromethyl)-2-thia-4-azabicyclo[4.1.0]­hept-3-en-5-yl]-4-fluorophenyl]-5-chloropyrazine-2-carboxamide (5) simultaneously satisfied the criteria for high predicted potency, favorable BBB penetration, low PgP efflux, and good synthetic accessibility. Molecular docking revealed that compound 5 binds strategically to the S1 and S3 substrate-recognition pockets through hydrogen bonds with THR280, GLN121, LYS155, as well as a halogen interaction with ARG283, while avoiding direct interaction with the catalytic dyad. This binding mode balances affinity and permeability, distinguishing compound 5 from clinically unsuccessful inhibitors. The practical implication is a rational framework that rapidly prioritizes candidates with high potency and favorable Central Nervous System (CNS) drug-like properties, thereby reducing the risk of late-stage attrition. All predictions are computational and require experimental validation (enzymatic, cellular, and in vivo) before any translational claims can be made. Thus, combining QSAR, ADMET, and molecular docking with an early emphasis on BBB penetration offers a time-efficient strategy for CNS drug discovery against Alzheimer’s disease.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• rcsb.org/structure/5hu0, at PDB; found in the text, “Binding Mode and Driving Forces”

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 3, 28 September 2026

• Funding: added Ministerio de Ciencia, Innovación y Universidades: PID2024-156686NB-I00, PID2024; Universidad Autónoma de Madrid; Universidad de La Habana; Fundación Carolina: 2024-2025

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 66 references.

Cite

This paper

Alvarez-Ginarte, Y., López, R., García de la Vega, J. M., De Ema, I., & Alpízar-Pedraza, D. (2026). Integrated Virtual Screening and Molecular Electrostatic Surface Potential Descriptors for Predicting BACE1 Inhibitor Interactions in Alzheimer's Disease. ACS omega, 11(32), 47739-47753. https://doi.org/10.1021/acsomega.6c02969

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1097/md.0000000000050324

Transcriptomic integration reveals immune heterogeneity in vascular dementia and identifies ELF2 as a candidate therapeutic target.

Journal: Medicine

In common: Alzheimer's / dementia, 1 reference

[2] doi:10.1007/s12035-026-05973-y

Integrative Transcriptomic, Network, and Machine Learning Analyses Identify Genistein and Resveratrol-Associated Therapeutic Targets in Alzheimer's Disease.

Journal: Molecular neurobiology

In common: Alzheimer's / dementia, 1 reference

[3] doi:10.3390/biomedicines14050998 [code]

Integrative Multi-Omics and Machine Learning Analysis Identifies Therapeutic Targets and Drug Repurposing Candidates for Alzheimer's Disease.

Journal: Biomedicines

In common: Alzheimer's / dementia, 1 reference

[4] doi:10.1021/acsomega.5c11807

Repurposing <i>T‑614</i> for Gout: An In Silico Framework Integrating Network Pharmacology, Mendelian Randomization, and Single-Cell and Molecular Dynamics Analyses.

Journal: ACS omega

In common: 1 reference

[5] doi:10.1021/acsptsci.5c00821

Blood-Brain Barrier (BBB)-Penetrable Androgen Receptor (AR) Degrader as a Potential Therapeutic Agent for Glioblastoma.

Journal: ACS pharmacology & translational science

In common: 1 reference

[6] doi:10.1038/s41467-026-75941-6

Structural and functional studies of inward rectifier Kir7.1 and its regulation by the Melanocortin-4 receptor.

Journal: Nature communications

In common: 1 reference

[7] doi:10.1007/s44297-026-00082-7

Functional conservation of IR75q.2 in the recognition of volatile acids and aldehydes in two Spodoptera species.

Journal: Crop health

In common: 1 reference

[8] doi:10.1007/s12035-026-06058-6

2-Phenyl-3-(Phenylselanyl)Benzofuran As a Promising Antidepressant Candidate: Mechanistic Insights Into Nitrergic Modulation and Subchronic Efficacy and Safety Profiling.

Journal: Molecular neurobiology

In common: 1 reference

[9] doi:10.1038/s41467-026-74888-y

Engineered zwitterion-nanodelivery for precision targeting of brain metastases.

Journal: Nature communications

In common: 1 reference

[10] doi:10.1186/s13293-026-00941-6

Prenatal BPA exposure perturbs RNA-binding protein-mediated splicing regulation and synaptogenesis in the developing cerebellum in a sex-dependent manner.

Journal: Biology of sex differences

In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.